ANIK Financial Facts
Cost of product revenue: 5MNet income: 0.61
See Full Income Statement
Total stockholders' equity: 214.54M
Total Assets: 231.06M
See Full Balance Sheet
Anika Therapeutics Inc. (ANIK) Earnings
|
Expand Research on ANIK
Next EPS Date | 5/2/24 | EPS Growth Rate | -63.6% |
---|---|---|---|
Average EPS % Beat Rate | +98.7% | Revenue Growth Rate | +9.6% |
Average % Move 1-Wk after EPS | -1.4% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/2/23 | Q323 | $0.00 | -$0.35 | +$0.35 | $41.5M | $38.27M | = | Details | |||
8/8/23 | Q223 | $0.06 | -$0.32 | +$0.38 | $44.3M | $40.37M | = | Details | |||
5/9/23 | Q123 | -$0.11 | -$0.24 | +$0.13 | $37.9M | $38.95M | = | Details | |||
2/23/23 | Q422 | N/A | -$0.24 | N/A | N/A | $37.71M | N/A | N/A | N/A | ||
3/6/23 | Q422 | -$0.34 | -$0.24 | -$0.10 | $39.62M | $37.71M | = | Details | |||
3/13/24 | Q423 | $0.05 | -$0.23 | +$0.28 | $43M | $41.4M | = | Details | |||
2/22/24 | Q423 | N/A | -$0.23 | N/A | N/A | $41.4M | = | N/A | N/A | ||
11/8/22 | Q322 | $0.04 | -$0.23 | +$0.27 | $39.54M | $38.11M | N/A | Details |